48,454
edits
Difference between revisions of "SMARCB1-deficient renal medullary carcinoma"
Jump to navigation
Jump to search
SMARCB1-deficient renal medullary carcinoma (view source)
Revision as of 01:52, 20 March 2024
, 20 Marchno edit summary
m (Michael moved page Renal medullary carcinoma to SMARCB1-deficient renal medullary carcinoma: WHO name) |
|||
| Line 19: | Line 19: | ||
| Assdx = [[sickle cell disease]] or sickle cell trait | | Assdx = [[sickle cell disease]] or sickle cell trait | ||
| Syndromes = | | Syndromes = | ||
| Clinicalhx = usu. young adults | | Clinicalhx = usu. young adults with [[sickle cell disease]] or sickle cell trait | ||
| Signs = | | Signs = | ||
| Symptoms = | | Symptoms = | ||
| Line 28: | Line 28: | ||
| Prognosis = poor | | Prognosis = poor | ||
| Other = | | Other = | ||
| ClinDDx = | | ClinDDx = other [[renal tumours]] | ||
| Tx = | | Tx = | ||
}} | }} | ||
''' | '''SMARCB1-deficient renal medullary carcinoma''' is a rare [[malignant]] [[kidney tumour]] associated with sickle cell trait and a poor prognosis. | ||
It was previously called '''renal medullary carcinoma''', abbreviated '''RMC'''. | |||
==General== | ==General== | ||